$350 | Single User
$700 | Site License
$1050 | Enterprise License

Biotechnology in Europe
[Lowest Price Guaranteed: $350]

Published by Marketline: 17 Dec 2019 | 260971 | In Stock
Related Topics: Biotechnology

Introduction

Biotechnology in Europe

Summary

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

- The European biotechnology industry had total revenues of .0bn in 2018, representing a compound annual growth rate (CAGR) of 6.3% between 2014 and 2018.

- The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of .4bn, equivalent to 63.2% of the industry's overall value.

- The medical/healthcare segment makes up the majority of the European industry. This is because in developed nations in Europe, an aging population has driven demand in the medical/healthcare segment, as an increasing number of people are suffering from long-term chronic diseases and healthcare costs have increased.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe

- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts

Reasons to Buy

- What was the size of the Europe biotechnology market by value in 2018?

- What will be the size of the Europe biotechnology market in 2023?

- What factors are affecting the strength of competition in the Europe biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Europe's biotechnology market?

Table of Contents
for Biotechnology in Europe

  • Table of Contents

    1 Executive Summary

    1.1. Market value

    1.2. Market value forecast

    1.3. Category segmentation

    1.4. Geography segmentation

    1.5. Market rivalry

    1.6. Competitive Landscape

    2 Market Overview

    2.1. Market definition

    2.2. Market analysis

    3 Market Data

    3.1. Market value

    4 Market Segmentation

    4.1. Category segmentation

    4.2. Geography segmentation

    5 Market Outlook

    5.1. Market value forecast

    6 Five Forces Analysis

    6.1. Summary

    6.2. Buyer power

    6.3. Supplier power

    6.4. New entrants

    6.5. Threat of substitutes

    6.6. Degree of rivalry

    7 Competitive Landscape

    7.1. Who are the leading players in the market?

    7.2. What strategies do leading players follow?

    7.3. What are the strengths of leading players?

    7.4. Have there been any new product launches in recent years?

    7.5. What has been the rationale behind recent strategic partnerships?

    7.6. Are there any threats to leading players?

    8 Company Profiles

    8.1. Merck & Co., Inc.

    8.2. Boehringer Ingelheim GmbH

    8.3. AstraZeneca PLC

    8.4. F. Hoffmann-La Roche Ltd

    9 Macroeconomic Indicators

    9.1. Country data

    10 Appendix

    Methodology 42

    10.1. Industry associations

    10.2. Related MarketLine research

    10.3. About MarketLine

List Of Tables
in Biotechnology in Europe

List of Tables

Table 1: Europe biotechnology industry value: $ million, 2014-18

Table 2: Europe biotechnology industry category segmentation: $ million, 2018

Table 3: Europe biotechnology industry geography segmentation: $ million, 2018

Table 4: Europe biotechnology industry value forecast: $ million, 2018-23

Table 5: Merck & Co., Inc.: key facts

Table 6: Merck & Co., Inc.: Annual Financial Ratios

Table 7: Merck & Co., Inc.: Key Employees

Table 8: Merck & Co., Inc.: Key Employees Continued

Table 9: Boehringer Ingelheim GmbH: key facts

Table 10: Boehringer Ingelheim GmbH: Key Employees

Table 11: AstraZeneca PLC: key facts

Table 12: AstraZeneca PLC: Annual Financial Ratios

Table 13: AstraZeneca PLC: Key Employees

Table 14: F. Hoffmann-La Roche Ltd: key facts

Table 15: F. Hoffmann-La Roche Ltd: Annual Financial Ratios

Table 16: F. Hoffmann-La Roche Ltd: Key Employees

Table 17: Europe size of population (million), 2014-18

Table 18: Europe gdp (constant 2005 prices, $ billion), 2014-18

Table 19: Europe gdp (current prices, $ billion), 2014-18

Table 20: Europe inflation, 2014-18

Table 21: Europe consumer price index (absolute), 2014-18

Table 22: Europe exchange rate, 2014-18

List Of Figures, Charts and Diagrams
in Biotechnology in Europe

List of Figures

Figure 1: Europe biotechnology industry value: $ million, 2014-18

Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2018

Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2018

Figure 4: Europe biotechnology industry value forecast: $ million, 2018-23

Figure 5: Forces driving competition in the biotechnology industry in Europe, 2018

Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2018

Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2018

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2018

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2018

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2018

Additional Details

Publisher

Marketline

Publisher Information

Reference

260971 |

Number of Pages

44

Report Format

PDF

Marketline Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review
Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review provides you...
24 Nov 2015 by Global Data USD $125 More Info
Puma Biotechnology, Inc. (PBYI) - Financial and Strategic SWOT Analysis Review
SummaryPuma Biotechnology, Inc. (Puma) is a biopharmaceutical company that develops and markets ther...
08 Nov 2015 by Global Data USD $300 More Info
Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis Review
SummaryPrana Biotechnology Limited (Prana Biotech) is a pharmaceutical company that develops therape...
08 Nov 2015 by Global Data USD $300 More Info
Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic SWOT Analysis Review
SummaryGenovate Biotechnology Co., Ltd. (GBL) is a pharmaceutical company that offers formulations. ...
08 Nov 2015 by Global Data USD $300 More Info
Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review
SummaryTamir Biotechnology, Inc. (formerly known as Alfacell Corporation) is a biopharmaceutical com...
08 Nov 2015 by Global Data USD $300 More Info
Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis Review
SummaryLevel Biotechnology Inc. (LBI) is a biotechnology company that offers molecular biology produ...
08 Nov 2015 by Global Data USD $300 More Info
G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic SWOT Analysis Review
SummaryG&E Herbal Biotechnology Co., Ltd. (G&E Herbal) is a biopharmaceutical company that offers re...
08 Nov 2015 by Global Data USD $300 More Info
Anhui Anke Biotechnology (Group) Co., Ltd. (300009) - Financial and Strategic SWOT Analysis Review
SummaryAnhui Anke Biotechnology (Group) Co., Ltd. (AnkeBio) is a biotechnology company that develops...
08 Nov 2015 by Global Data USD $300 More Info
Golden Biotechnology Corp. (4132) - Financial and Strategic SWOT Analysis Review
SummaryGolden Biotechnology Corp. (Golden Biotech) is a biotechnology company that develops drugs. T...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: Have expectations been reset for Puma Biotechnology's neratinib in HER2+ breast cancer?
Scope Investors appear to be resetting their expectations for Puma Biotechnology's experimental HER2...
01 May 2015 by FirstWord Pharma USD $695 More Info

This report is published by Marketline

Download Free Report Summary PDF

Biotechnology in Europe | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...